The largest database of trusted experimental protocols

Recombinant human tgf β1

Manufactured by R&D Systems
Sourced in United States, United Kingdom, Germany, China, Japan

Recombinant human TGF-β1 is a cytokine that regulates a variety of cellular processes, including cell growth, cell differentiation, and immune function. It is produced using recombinant DNA technology.

Automatically generated - may contain errors

372 protocols using recombinant human tgf β1

1

Immunomodulatory effects of BM-MSCs on T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse splenic CD4+ T lymphocytes were isolated using a mouse CD4+ T Cell Isolation Kit (Miltenyi Biotec; Auburn, CA, USA) with magnetic beads following the manufacturer’s instructions. Mandibular BM-MSCs at passage 2–4 from control mice or periodontitis mice after the indicated manipulation of gene expression were seeded on 24-well plates at a concentration of 1 × 105 cells/well and incubated overnight before they were co-cultured with activated mouse CD4+ T cells. Mouse T lymphocytes were pre-activated in RPMI 1640 medium supplemented with 10% heat-inactivated FBS, 50 μM 2-mercaptoethanol, 10 mM HEPES, 2 mM L-glutamine, 100 U/mL penicillin, and 100 mg/mL streptomycin (all reagents were from Thermo Fisher Scientific) by plate-bound anti-CD3 antibody (1:1000 dilution; #ab16669; Abcam, USA) and soluble anti-CD28 antibody (1:5000 dilution; #ab283860, Abcam, USA) for 2–3 days in 24-well plates. Recombinant human TGF-β1 (2 ng/mL; R&D Systems, Minneapolis, MN, USA) and IL-2 (2 ng/mL; R&D Systems) were added into the culture medium to induce Treg differentiation; while Recombinant human TGF-β1 (2 ng/mL; R&D Systems) and IL-6 (50 ng/mL; R&D Systems) were added to induce Th17 differentiation. The activated mouse CD4+ T cells were loaded on the adherent BM-MSCs and co-cultured for further 2–3 days. The supernatant and T cells on top layers were collected for further analyses.
+ Open protocol
+ Expand
2

Culturing and Authentication of Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
EPC2T and OKF6T were generated and cultured in keratinocyte-serum free medium (KSFM; Thermo Fisher Scientific, Waltham, MA, USA) as described previously.10 (link), 22 (link), 40 (link) TE11 cells were cultured in Dulbecco’s Modified Eagle Medium (Thermo Fisher Scientific) as previously described.40 (link) Countess Automated Cell Counter (Thermo Fisher Scientific) was used to count cells with 0.2% Trypan Blue dye to exclude dead cells. Recombinant human TGF-β1 (R&D Systems, Minneapolis, MN, USA) was reconstituted in Dulbecco’s Phosphate Buffered Saline (DPBS) containing 10% FBS. Chloroquine diphosphate solid salt (Sigma-Aldrich, St Louis, MO, USA) was reconstituted in water. CDDP (Sigma-Aldrich) and 5FU (Sigma-Aldrich) were dissolved in DMSO. Organotypic 3D culture (OTC) was carried out as described previously.19 (link) The earliest frozen stocks of all cell lines are stored at the Cell Culture Core of the University of Pennsylvania. We have propagated cells from frozen stocks of original vials that were authenticated by short tandem repeat profiling (ATCC) for highly polymorphic microsatellites to validate the identity of cells by comparing cells at the earliest stocks and those grown >8–12 passages. All cell lines undergo routine mycoplasma testing.
+ Open protocol
+ Expand
3

Culturing and Differentiating Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDA-MB-231 breast cancer cells38 (link) (HTB-26, ATCC, Manassas, VA), MCF-7 breast cancer cells39 (link) (HTB-22, ATCC), ZR75-1 breast cancer cells40 (link) (CRL-1500, ATCC), PC-3 prostate cancer cells41 (link) (CRL-1435, ATCC), and RWGT2 lung cancer cells15 (link),42 (link) (isolated from bone metastases by Dr. Guise as reported15 (link)) were cultured in Dulbecco's modified Eagle's media (DMEM) (Hyclone, Logan, UT) containing 10% heat-inactivated fetal bovine serum (FBS) (Hyclone). JJN-3 multiple myeloma cells43 (link) (ACC 541, DSMZ) were cultured in RPMI 1640 (Invitrogen, Grand Island, NY) containing 10% heat-inactivated FBS. A549 cancer cells (CCL-185, ATCC) were cultured in 1640 RPMI (Hyclone) containing 10% heat-inactivated FBS. C2C12 myoblast cells (CRL-1772, ATCC) were cultured subconfluently in DMEM containing 10% heat-inactivated FBS. C2C12 myoblasts were differentiated into myotubes by culture in DMEM containing 2% heat-inactivated horse serum (HS) (Hyclone). All cells were maintained at 37° C with 5% CO2 in a humidified chamber. All cells were verified to be free of mycoplasma contamination via routine PCR testing. No independent verification was completed. Cells treated with recombinant human TGF-β1 (R&D Systems, Minneapolis, MN) were starved in DMEM (no serum) for 16-20 hrs and 5 ng/ml TGF-β1 was added to cells in DMEM.
+ Open protocol
+ Expand
4

Molecular Mechanisms of TGF-β1-Mediated Apoptosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human TGF-β1 was purchased from R&D Systems (Minneapolis, MN, USA), emodin was obtained from Shanghai future industry Limited by Share Ltd (Shanghai, China) and BLM was acquired from Nippon Kayaku (Tokyo, Japan). The primary antibodies described in the study include: anti-E-cadherin, anti-vimentin, anti-cleaved caspase-3, anti-phospho-Smad2, anti-phospho-Smad3, anti-Smad2, anti-Smad3, anti-phospho-Erk1/2 and anti-Erk1/2 (Cell Signaling Technology, CA, USA); anti-caspase-3, anti-Bax (Santa Cruz Biotechnology, CA, USA); anti-fibronectin (Proteintech, Chicago, USA); anti-caspase-8, anti-Bcl-2 (Absci, MD, USA); anti-TGF-β1, anti-FSP-1, anti-α-SMA (Abcam, USA); and anti-GAPDH (Beyotime Institute of Biotechnology, Haimen, China). Other reagents were obtained from Beyotime Institute of Biotechnology unless otherwise indicated.
+ Open protocol
+ Expand
5

Anthocyanidins Modulate Epithelial-Mesenchymal Transition

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anthocyanidin compounds Cy (purity ≥ 96%), Dp, Pg, Mv (purity ≥ 97%) and Pt (purity ≥ 95%) were from Extrasynthese (Lyon, France). Recombinant human TGF-β1 was from R&D Systems (Minneapolis, MN). Electrophoresis reagents were from Bio-Rad (Mississauga, ON). The anti-Twist1 monoclonal antibody was from Santa Cruz Biotechnologies (Dallas, TX). The anti-Periostin antibody was from Abcam (Cambridge, MA). Antibodies against Snail, phospho-Smad2, Smad2, GAPDH (glyceraldehyde-3-phosphate dehydrogenase), vimentin, β-Catenin, phospho-Fak, Fak, phospho-Akt and Akt were from Cell Signaling Technology (Beverly, MA). The anti-fibronectin antibody was from Sigma Aldrich (Oakville, ON). Anti-mouse and anti-rabbit horseradish peroxidase (HRP)-linked secondary antibodies were from Jackson ImmunoResearch Laboratories (West Grove, PA) and enhanced chemiluminescence (ECL) reagents were from Denville Scientific Inc. (Metuchen, NJ). Micro bicinchoninic acid protein assay reagents were from ThermoFisher Scientific (Rockford, IL).
+ Open protocol
+ Expand
6

Knockdown Effects on Class Switch Recombination

Check if the same lab product or an alternative is used in the 5 most similar protocols
Class switch recombination was performed in CH12F3-2a cells as described previously50 (link). Briefly, RNF8, RNF168, L3MBTL2 or a combination of these, was knocked down using shRNAs. 40 hours later, cells were stimulated with ligands [1 ng/ml of recombinant human TGF-β1 (R&D Systems), 10 ng/ml of recombinant murine IL-4 (R&D Systems), and 250 ng/ml recombinant murine CD40 ligand (PerproTech)]. For analyzing class switch from IgM (IgM+/IgA−) to IgA (IgM−/IgA+), CH12F3-2 cells were collected after 60 hours, intracellularly stained with PE-conjugated anti-murine IgA antibody (clone 11–44-2, eBiosciences, Cat# 12-5994-82). Membrane IgM expression was assessed using FITC-conjugated anti-murine IgM antibody (eBiosciences; Cat# 11-5890-82). Cytofix/Cytoperm and Perm/Wash buffers (BD Biosciences, catalog # 554714) was utilized. Cells were then analyzed on a FACS Calibur (BD Biosciences) at the Mayo Clinic Flow Cytometry Core. Data was analyzed using FlowJo software (TreeStar).
+ Open protocol
+ Expand
7

Isolation and Stimulation of Human PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human peripheral blood mononuclear cells were isolated from healthy volunteers and stored at −80°C in cryovials at a 107-cell/ml concentration in FBS containing 10% DMSO. Before plating, cells were washed in PBS twice, recounted, and plated at a 106-cell/ml concentration in RPMI medium supplemented with 10% FBS and 1% penicillin-streptomycin-glutamine. Cells were stimulated for 3 days as described previously (12 (link)) with anti-human CD3 (BD no.555336, 0.3 µg/ml), anti-human CD28 (BD no.555725, 2 µg/ml) and recombinant human TGF-β1 (R&D no. 240B002, 2.5 ng/ml).
Bacteria isolated from human chloroform-resistant cultures were resuspended in PBS supplemented with protease inhibitor (Roche no. 4693159001) and phosphatase inhibitor (Roche no. 4906845001), heat-inactivated at 65°C for 1 h and sonicated for 10 min as described previously (14 (link)). Protein concentration in the resulting suspension was measured using the Pierce BCA protein assay kit (Thermo Scientific no. 23227). Bacterial extracts were added to PBMCs at 1 µg/ml 1 h after plating as described previously (13 (link)). PBS with the same protease inhibitor and phosphatase inhibitor was added as the no-bacterium control. Each human in vitro experiment contained at least 6 independent donor bacterial samples and was repeated at least twice.
+ Open protocol
+ Expand
8

TGF-β1 Signaling Pathway Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following reagents were obtained from the respective commercial vendors. Recombinant human TGF-β1 from R&D Systems (Minneapolis, MN, USA), losartan from Selleck Chemicals (Houston, TX, USA), dexamethasone from Sigma-Aldrich (St. Louis, MO, USA), ganciclovir from Selleck Chemicals, normal horse serum (RTU Vectastain Universal Elite ABC Kit) from Vector Laboratories (Burlingame, CA, USA), murine monoclonal anti-CMV IE antibody (anti-CMV Immediate Early Antigen Antibody, #LS-C103255) from LSBio (Seattle, WA, USA), a goat anti-mouse antibody (VectaFluor R.T.U. DyLight 488 anti-mouse) from Vector Laboratories, rhodamine phalloidin and Vecta-Stain mounting media (VECTASHIELD) from Invitrogen (Carlsbad, CA, USA), a TGF-β1 enzyme-linked immunosorbent assay (ELISA) kit (Total TGF-β1 ELISA Kit with precoated plates) from BioLegend (San Diego, CA, USA), and a MTS assay kit (CellTiter 96® AQueous One Solution Cell Proliferation Assay) from Promega (Medison, WI, USA).
+ Open protocol
+ Expand
9

Regulation of Myofibroblast Differentiation by CTGF

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the role of CTGF in TGF-β1-induced myofibroblast differentiation, we used CTGF siRNA (5′-GAGAGACATTAACTCATTA-3′, cat. J-012633–13–05, GE Dharmacon) to knock-down expression of CTGF. Non-targeting siRNA (cat. D-001810-01-05, GE Dharmacon) was used as a negative control. Lipofectamine RNAiMAX (Invitrogen) reagent was used to perform siRNA transfections as per the manufacturer’s instructions. Briefly, 1×105 cells/6-well plate were seeded in DMEM/F12 with 5% HS. After attachment, cells were changed into reduced serum-containing media for 1 day, then transfected with CTGF siRNA or control siRNA. About 24 hours after transfection, cells were treated with recombinant human TGF-β1 (1 ng/ml, R&D Systems, Inc.; Minneapolis, MN). Two days later, cells were harvested and Western blots were used to estimate the expression of CTGF and αSMA relative to that of β-Tubulin.
+ Open protocol
+ Expand
10

TGF-β Signaling Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Polyclonal anti-CTGF (diluted at 1:1000) and monoclonal anti-α-tubulin (diluted at 1:5000) antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Polyclonal anti-Smad4 (diluted at 1:1000), anti-TGF-β receptor type I (diluted at 1:1000), anti-ERK1/2 (diluted at 1:2000), monoclonal anti-Smad2 (diluted at 1:1000) and anti-Smad3 (diluted at 1:1000) antibodies were obtained from Cell Signaling Technology (Danvers, MA). Horseradish peroxidase-conjugated goat anti-mouse and goat anti-rabbit IgG (diluted at 1:5000) were obtained from Bio-Rad Laboratories (Hercules, CA), and horseradish peroxidase-conjugated donkey anti-goat IgG (diluted at 1:5000) was obtained from Santa Cruz Biotechnology. Recombinant human TGF-β 1 was obtained from R&D systems (Minneapolis, MN). SB431542 was obtained from Sigma-Aldrich (Oakville, ON), and U0126 was obtained from Calbiochem (San Diego, CA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!